The FDA has approved the newest version of COVID-19 vaccines for fall 2025, but only for certain high-risk groups: adults 65 and older and people with underlying conditions. The decision has already sparked concern among pediatricians and vaccine advocates who say the move leaves infants, healthy children, and pregnant women without clear access.
Health Secretary Robert F. Kennedy Jr. announced on Twitter that Moderna, Pfizer, and Novavax vaccines are still available for those who consult with their doctor. But emergency authorizations for kids under five have been rescinded, meaning healthy toddlers and babies are no longer eligible for standard vaccination.
“Our health care system is now solidly anti-children and anti-science,” said Fatima Khan of Protect Their Future, a nonprofit pushing for vaccine access. Pediatric leaders warn that the decision could lead to preventable hospitalizations and more confusion for parents.
Dr. Susan Kressly of the American Academy of Pediatrics said, “Any parent who wants their child vaccinated should have access.” Meanwhile, infectious disease experts say off-label access might be possible but would be more complicated.
The CDC recently updated its immunization guidance to remove blanket recommendations for children and pregnant women, placing responsibility on families and physicians. Yet COVID hospitalizations remain highest among the very young and the elderly, even as virus levels continue rising nationwide.
Dr. Tina Tan called the FDA’s move a “dangerous” shift that undermines public trust and puts millions at risk. With infections climbing, especially among vulnerable age groups, many fear this policy change could cost lives.
